Objective. Pancreaticoduodenectomy is the standard of care for tumors confined to the head of pancreas and can be undertaken with low operative mortality. The procedure has a high morbidity, particularly in older patient populations with preexisting comorbidities. This study evaluated the role of cardiopulmonary exercise testing to predict postoperative morbidity and outcome in high-risk patients undergoing pancreaticoduodenectomy. Methods. In a prospective cohort of consecutive patients undergoing pancreaticoduodenectomy, those aged over 65 years (or younger with comorbidity) were categorized as high risk and underwent preoperative assessment by cardiopulmonary exercise testing (CPET) according to a predefined protocol. Data were collected on functional status, postoperative complications, and survival. Results. A total of 143 patients underwent preoperative assessment, 50 of whom were deemed to be at low risk for surgery per study protocol. Of 93 high-risk patients, 64 proceeded to surgery after preoperative CPET. Neither anaerobic threshold (AT) nor maximal oxygen consumption ( _ V O 2 MAX) predicted patient mortality or morbidity. However, ventilatory equivalent of carbon dioxide ( _ V E/ _ V CO 2 ) at AT was a predictive marker of postoperative mortality, with an area under the curve (AUC) of 0.84 (95 % confidence interval [CI] 0.63-1.00, p = 0.020); a threshold of 41 was 75 % sensitive and 95 % specific (positive predictive value 50 %, negative predictive value 98 %). Above this threshold, raised _ V E/ _ V CO 2 predicted poor longterm survival (hazard ratio 2.05, 95 % CI 1.09-3.86, p = 0.026).
ABSTRACT
Objective. Pancreaticoduodenectomy is the standard of care for tumors confined to the head of pancreas and can be undertaken with low operative mortality. The procedure has a high morbidity, particularly in older patient populations with preexisting comorbidities. This study evaluated the role of cardiopulmonary exercise testing to predict postoperative morbidity and outcome in high-risk patients undergoing pancreaticoduodenectomy. Methods. In a prospective cohort of consecutive patients undergoing pancreaticoduodenectomy, those aged over 65 years (or younger with comorbidity) were categorized as high risk and underwent preoperative assessment by cardiopulmonary exercise testing (CPET) according to a predefined protocol. Data were collected on functional status, postoperative complications, and survival. Results. A total of 143 patients underwent preoperative assessment, 50 of whom were deemed to be at low risk for surgery per study protocol. Of 93 high-risk patients, 64 proceeded to surgery after preoperative CPET. Neither anaerobic threshold (AT) nor maximal oxygen consumption ( _ V O 2 MAX) predicted patient mortality or morbidity. However, ventilatory equivalent of carbon dioxide ( _ V E/ _ V CO 2 ) at AT was a predictive marker of postoperative mortality, with an area under the curve (AUC) of 0.84 (95 % confidence interval [CI] 0.63-1.00, p = 0.020); a threshold of 41 was 75 % sensitive and 95 % specific (positive predictive value 50 %, negative predictive value 98 %). Above this threshold, raised _ V E/ _ V CO 2 predicted poor longterm survival (hazard ratio 2.05, 95 % CI 1.09-3.86, p = 0.026).
Conclusions. CPET is a useful adjunctive test for predicting postoperative outcome in patients being assessed for pancreaticoduodenectomy. Raised CPET-derived _ V E/ _ V CO 2 predicts early postoperative death and poor long-term survival.
Surgical resection is the standard of care for patients with tumors confined to the head of the pancreas. [1] [2] [3] An increasing number of reports attest that pancreaticoduodenectomy can be performed with low operative mortality. 2, 4 However, perioperative morbidity remains high, and the risk-benefit ratio of complex resectional surgery must be carefully assessed. 5 Thus, one of the principal thrusts of current pancreatic oncological surgery is toward optimal patient selection.
Detailed oncological staging can be undertaken with a combination of high-resolution cross-sectional imaging combined with endoscopic ultrasonography. Assessment of risk in terms of cardiorespiratory comorbidity is an integral component of preoperative assessment. This is particularly relevant when it is considered that pancreatic adenocarcinoma is predominantly a disease of later life and that patients assessed for resection may be at high risk for postoperative cardiac or pulmonary complications. Furthermore, postoperative complications may affect uptake of adjuvant chemotherapy, potentially leading to adverse outcome. 6 The current methods of evaluating perioperative risk rely on tools comprising subjectively derived assessments of functional capacity, such as the Revised Cardiac Risk Index (RCRI) or the Physiological and Operative Severity Score for Enumeration of Morbidity and Mortality. These measures, along with other forms of functional assessments (shuttle walk test, Duke score), have been shown to be poor surrogates for functional cardiopulmonary assessment. 7, 8 Cardiopulmonary exercise testing (CPET) provides an accurate and reliable noninvasive assessment of cardiopulmonary function. CPET-derived variables have been demonstrated to provide prognostic information relating to outcome after major intra-abdominal surgery. 7, 9 Despite validation in a heterogeneous general surgical population, its evaluation in pancreatic resectional surgery is limited either in an exclusive cohort or as an independently reported subgroup of a broader cohort. Thus, the aim of the present study was to assess the role of preoperative CPET for prediction of perioperative outcome in a cohort of patients scheduled to undergo pancreaticoduodenectomy.
METHODS

Study Design
This single-center prospective cohort study evaluated outcomes in patients undergoing pancreaticoduodenectomy. CPET was used for preoperative risk assessment in protocol-defined high-risk patients.
Study Population
The study cohort comprised a consecutive series of patients undergoing pancreaticoduodenectomy at a tertiary hepatobiliary surgery referral center. The study was undertaken over a 39-month period from September 1, 2007, to December 31, 2010. Staging of primary disease was undertaken using high-resolution, contrast-enhanced computed tomography together with endoscopic ultrasound (and endoscopic ultrasound-guided fine needle aspiration for cytological and biochemical analysis) in patients with cystic lesions. Patients presenting with obstructive jaundice routinely underwent endoscopic retrograde cholangiopancreatography with placement of an endobiliary stent or percutaneous transhepatic biliary drainage.
After clinical assessment, individuals with preexisting comorbidity or older than 65 years were further assessed by preoperative CPET in compliance with a predefined hepatopancreato-biliary unit protocol. These patients were classified as high risk. Younger individuals (B65 years) with no significant preexisting comorbidity proceeded to surgery without preoperative CPET and were classified as the low risk.
Patient-level Data and Disease Descriptors
Baseline data were recorded for all patients, including age, gender, and preoperative hematological and biochemical profile, which included full blood count, liver function tests, renal function tests, and C-reactive protein.
Operative details (duration of surgery and intraoperative blood transfusion) were also recorded.
The primary outcome studied was postoperative mortality (defined as death within 30 days of operation). Secondary outcomes included in-hospital mortality occurring beyond the 30th postoperative day (time unlimited), intensive care unit (level III critical care) stay, highdependency unit (level II critical care) stay, overall hospital stay, and longer-term survival with follow-up to 4 years. Long-term survival was also evaluated separately in patients who underwent preoperative assessment with CPET but who failed to undergo pancreatic resection, either because of advanced disease or because they were deemed unfit for major surgery.
An enhanced set of data were obtained for patients undergoing CPET, including self-reported history of smoking and preoperative comorbidities. Preoperative comorbidity was recorded at initial clinical assessment and included data on the following: cardiac-history of hypertension or ischemic heart disease; diabetes mellitus (insulin dependent or otherwise); history of cerebrovascular disease; and chronic obstructive airways disease or renal impairment (defined according to the National Institute for Health and Clinical Excellence guidance on chronic kidney disease). 10 In this subset, preoperative functional status was assessed using the American Society of Anesthesiologists (ASA) score and the 6-point RCRI, including high-risk surgical procedure, history of ischemic heart disease, history of heart failure, cerebrovascular disease, insulin-dependent diabetes, and preoperative serum creatinine concentration of C177 lmol/L. Other predictors of postoperative risk including body mass index (BMI) and the Glasgow prognostic score (GPS) were collected prospectively to permit comparison with CPET data.
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Postoperative morbidity was defined using the International Study Group for Pancreatic Surgery (ISGPS) classification for postpancreaticoduodenectomy complications of postoperative pancreatic fistula, delayed gastric emptying, and postpancreaticoduodenectomy hemorrhage. [11] [12] [13] [14] Cardiac complications included acute myocardial infarction (detection of a rise in serum troponin) and electrocardiographic (ECG) changes indicative of new ischemia; congestive cardiac failure; and serious dysrhythmia resulting in compromised tissue perfusion and primary cardiac arrest. Pulmonary complications included pneumonia, pleural effusion, and respiratory failure requiring ventilatory support. Renal complications included acute kidney injury, defined as an increase in baseline creatinine of 1.5-fold and/or a requirement for renal replacement therapy. Other recorded complications included confusion, cerebrovascular accidents, wound infections, thromboembolic events, intra-abdominal sepsis, and interventions (radiological, endoscopic, or surgical), which included return to the operating theater. Complications were recorded for the entire postoperative in-hospital period.
Data were recorded prospectively and analyzed at completion of the study. All-cause mortality was determined using the Demographics Batch Service to access the national electronic database of the UK National Health Service.
CPET Protocol
Preoperative CPET was carried out once the decision to undertake pancreaticoduodenectomy was made and patients met the inclusion criteria for CPET as per protocol. CPET results were available to clinicians before surgery. An established study protocol was followed, and the test was carried out and interpreted by two observers (a clinical scientist and an attending anesthetist). 15 CPET equipment (Ultima CardiO 2 , MedGraphics, USA) included an electronically braked cycle ergometer with a 12-lead ECG and a metabolic cart with a face mask for gas analyses. Calibration was carried out before each test for flow measurement and gas analyzers.
The test was divided into four phases. The first phase involved a 2-to 5-min rest period to ensure a respiratory exchange rate of less than 1. The respiratory exchange rate is the ratio of volume of carbon dioxide elimination ( _ V CO 2 L/min) to oxygen consumption ( _ V O 2 L/min). The second phase of unloaded cycling for 3 min was followed by the ramp phase in continuous increments maintaining greater than 60 revolutions per minute (RPM). The test ended with the recovery phase to allow the ECG and heart rate to return to baseline levels. The test was terminated if patients developed ECG changes (ST changes [2.0 mm depression or [3.0 mm elevation, new dysrhythmia), near syncope, or failed to maintain greater than 50 RPM.
AT was determined using the modified V-slope method and was confirmed by changes in ventilatory efficiency for oxygen ( _ V E/ _ V O 2 ) and end-tidal values for oxygen (PETO 2 ) in which _ V E (L/min) is minute ventilation representing volume of gas expired per minute. 16, 17 Peak _ V O 2 was expressed as the highest mean oxygen consumption value ( _ V O 2 ) obtained from 5 rolling breath-to-breath measures during the last part of the incremental ramp stage. The ventilatory equivalence for carbon dioxide ( _ V E/ _ V CO 2 ) was determined as the ratio of minute ventilation to carbon dioxide elimination ( _ V CO 2 ) at AT.
Statistical Methods
Per protocol analysis was performed by SPSS version 16.0 software (IBM, Armonk, NY) with appropriate statistical tests for each variable type. Because the purpose of the study was hypothesis generation, a value of p \ 0.05 was regarded as significant, without correction for multiple testing. CPET (continuous) variables were evaluated using simple logistic regression to determine their potential prognostic value in predicting mortality or morbidity outcomes. Logistic regression models include a constant term and are reported as the exponential of the variable coefficient (odds ratio). If more than one variable predicted an outcome, then forward stepwise multiple variable regression was conducted. Significant CPET variables were further explored by plotting receiver operating characteristic (ROC) curves to identify threshold values, which discriminated effectively between patient groups with differing clinical outcomes.
Using these threshold values, survival analysis was conducted by the Kaplan-Meier method to identify discrete groups with varying prognosis. Differences in survival curves were assessed using the log rank method because this gives equal weight to events at all points in time. Putative models were further evaluated by Cox regression.
The study was registered as a prospective audit with the Research and Innovation Division of the Central Manchester University Hospitals NHS Foundation Trust (reference 1840).
RESULTS
Over a 39-month period, from September 1, 2007, to December 31, 2010, a total of 143 consecutive patients with operable pancreatic disease requiring pancreaticoduodenectomy were assessed for perioperative risk (Fig. 1 ). Per protocol, 93 patients were designated as being at high risk for preoperative assessment with CPET. Of these, 4 were unable to undergo CPET before surgery and proceeded to resection (in view of surgeon and patient preference) without CPET; 64 underwent pancreaticoduodenectomy after CPET; and a further 25 did not proceed to resection because of a combination of staging-detected advanced disease and/or comorbidity. The low-risk patient group comprised 50 patients, all of whom underwent resection, giving a total population of 118 undergoing pancreaticoduodenectomy.
Baseline characteristics and postoperative outcomes in these 118 patients are provided in Table 1 . No significant difference was noted between the low-and high-risk groups in the incidence of preoperative obstructive jaundice, use of preoperative biliary drainage, preoperative bilirubin levels, or postoperative intensive care unit stay. The durations of treatment in high-dependency units and hospital stays were significantly longer in the high-risk group.
An enhanced set of data collected in the high-risk CPET group is detailed in Table 2 . Of the 64 consecutive pancreaticoduodenectomies, CPET was inadequate in 4 individuals, leaving 60 patients contributing data to analyses.
Postoperative Mortality
Early (30-day) and late (all in-hospital) postoperative deaths are reported in Table 1 . Postoperative mortality was generally low, with no significant difference between low-and high-risk groups at 30 days (p = 0.223). All postoperative deaths resulted from surgical complications.
In high-risk patients, simple logistic regression analyses identified _ V E/ _ V CO 2 to be the CPET parameter most strongly associated with 30-day mortality (odds ratio 1.35, 95 % confidence interval [CI] 1.03-1.77, p = 0.030). Simple regression did not reveal any other CPET markers associated with early postoperative death (Table 3) . For inhospital mortality, simple logistic regression similarly fitted _ V E/ _ V CO 2 (odds ratio 1.26, 95 % CI 1.06-1.53, p = 0.013).
The ROC curves of _ V E/ _ V CO 2 for 30-day and all inhospital postoperative mortality are shown in Fig. 2 . For 30-day mortality, the AUC was 0.95 (95 % CI 0.89-1.02, p = 0.030) with 100 % sensitivity and 92 % specificity. For all in-hospital mortality, the AUC was 0.84 (95 % CI 0.63-1.07, p = 0.020). Given the small number of deaths at 30 days, in-hospital mortality was considered to be a more informative variable. A cutoff at 41.0 provided test sensitivity of 75 % (95 % CI 0.30-0.95), specificity of 93 % (95 % CI 0.85-0.98), positive predictive value of 50 % (95 % CI 0.19-0.81), and negative predictive value of 98 % (95 % CI 0.90-0.99). Thus, a negative result effectively ruled out 30-day hospital mortality, while 1 in 2 patients above threshold died before discharge.
Among traditional preoperative markers (ASA, RCRI, BMI, GPS, and obstructive jaundice), none was a statistically significant predictor of 30-day or in-hospital mortality. However, all 5 in-hospital deaths occurred in patients with an ASA score of 3 (p = 0.087, exact test).
Postoperative Morbidity
No CPET preoperative variable was a significant predictor (p \ 0.05) of complications by simple logistic regression (Table 3) . However, obstructive jaundice was associated with cardiopulmonary complications (odds ratio 5.40, 95 % CI 1.66-17.56, p = 0.005).
ISGPS Defined Postpancreatectomy Complications
ISGPS defined complications of postoperative pancreatic fistula, postpancreatectomy hemorrhage, and delayed gastric emptying are reported in 
Survival
The median period of follow-up for all 143 patients undergoing assessment for resection was 1,057 (range 424-1,657) days. For the 118 patients undergoing pancreaticoduodenectomy, the median follow-up period was 997 (range 424-1,596) days.
Survival analysis (Kaplan-Meier) identified discrete survival patterns using the CPET threshold value for _ V E/ _ V CO 2 of 41 (Fig. 3) . Patients above this threshold had a substantially poorer survival than patients below this threshold (hazard ratio 2.05, 95 % CI 1.09-3.86, p = 0.026). For comparison, the lower-risk patient groups (not undergoing CPET) are shown, with better survival as a result of younger age and associated risk markers.
Histologic subtypes [ductal adenocarcinoma 27 (41 %), ampullary 13 (20 %), intraductal papillary mucinous neoplasm 5 (7 %), distal duct cholangiocarcinoma 3 (5 %), duodenal adenocarcinoma 3 (5 %), chronic pancreatitis 3 (5 %), neuroendocrine tumor 2 (3 %), metastatic seminoma 1 (2 %), metastatic renal cancer 1 (2 %), autoimmune pancreatitis 2 (3 %), benign adenoma 3 (5 %), and benign distal bile duct stricture 1 (2 %)] showed no correlation with outcome (log-rank Mantel Cox test, p = 0.72). However, ductal adenocarcinoma was associated with a worse survival when compared to all other tumor types (log-rank Mantel Cox test, p = 0.001). 
DISCUSSION
This study reports an exploratory prospective cohort of high-risk patients undergoing pancreaticoduodenectomy with CPET for preoperative risk assessment. CPET-derived _ V E/ _ V CO 2 ratio at AT with a cutoff at 41 was the best predictor of postoperative in-hospital mortality and longterm survival in this high-risk pancreaticoduodenectomy population. Commonly used risk markers including ASA, RCRI, and BMI were not predictive of adverse outcome in this cohort, although this may be due to the small number of events.
There are a number of potential limitations when interpreting these findings. As in any hypothesis-generating study, the findings should undergo external validation by other investigators in similar patient cohorts. The _ V E/ _ V CO 2 threshold was determined for a high-risk cohort of pancreaticoduodenectomy patients and was limited by a low event rate in postoperative mortality. Further evaluation in 
, demonstrating the optimal cutoff for 30-day and all inhospital mortality in patients who underwent resection after CPET. For 30-day mortality, the AUC was 0.95; sensitivity and specificity were 100 and 92 %, respectively, at a cutoff threshold of 41. For inhospital death, the AUC was 0.84; sensitivity and specificity were 75 and 93 %, respectively, at a cutoff threshold of 41 Curves are truncated when less than 10 % of the cohort remains. The low-risk resection group represented individuals younger than 65 years of age, with no comorbidity (n = 50). High-risk group included individuals with preexisting comorbidity or age 65 years and over. A total of 89 of these high-risk patients underwent preoperative CPET evaluation, with 64 proceeding to resection. The remaining 25 patients had disease deemed inoperable, either as a result of high operative risk (n = 13) or advanced disease (n = 12). CPET was inadequate in 4 patients undergoing resection and 1 patient with advanced disease. Eighty-four patients provided data for survival analyses a larger cohort would be required to validate the utility of this marker of postoperative mortality. Another potential limitation is the lack of blinding of CPET results to clinicians; the availability of results to inform decision making potentially undermines the strength of association between variables and outcome measures, although it is unlikely that CPET findings modified surgical decisions because their importance was not known at the time that patients underwent surgery. An important bias in accurate preoperative evaluation of cardiopulmonary function is introduced by the presence of malignant obstructive jaundice. Obstructive jaundice is known to adversely affect global cardiac function. 18 Because increase in cardiac output remains the predominant mechanism of meeting increased oxygen demands after major abdominal surgery, the clinical impact of obstructive jaundice on postoperative outcomes in the context of pancreatic surgery remains unclear. [19] [20] [21] Further, the subjective dichotomization of patients into high-risk and low-risk groups means that CPET was not used in a group designated as low risk. The reason for this is that CPET data from other studies indicate that the validity of this test is maximal in assessing high-risk patients, but it should be acknowledged that if the test had been applied to all patients, different results may have been obtained. 22 In complex pancreatic resectional surgery, intraoperative factors including host-specific features (such as texture of pancreas and caliber of pancreatic duct), histologyrelated features (such as whether resection is for pancreatic ductal adenocarcinoma or other disease), and operatorspecific features (such as surgeon and hospital volume) have an important and profound influence on outcome. Preoperative CPET will not substitute for these important predictors but rather helps inform the decision of patient selection.
Despite these shortcomings, a CPET-derived variable provided an adequate predictor of mortality-related outcomes to augment the decision-making process by predicting early and long-term survival. A _ V E/ _ V CO 2 threshold of 41 as a predictor of postoperative and longterm survival is similar to the findings of Carlisle and Swart, reporting _ V E/ _ V CO 2 above 42 as the strongest predictor of 30-day and midterm survival after elective abdominal aortic aneurysm repair. 22 Our findings suggest that functional capacity as assessed by _ V E/ _ V CO 2 is a strong predictor of early and late postoperative outcome and may have a greater role to play than primary pancreatic pathology or resectability of cancer alone.
Although it is clear that CPET-derived functional assessment outperforms other methods as a predictor of postoperative and long-term survival, its clinical utility in pancreaticoduodenectomy lies in acting as an adjunct to other forms of assessment and in allowing the clinician and the patient to make more informed decisions about the relative risks and benefits of surgery.
